How Could the Price of Remdesivir Impact Medicare Spending for COVID-19 Patients?
(Juliette Cubanski, Karyn Schwartz, and Tricia Neuman for Kaiser Family Foundation) On May 1, 2020, the Food and Drug Administration
Read More
Part D/Prescription Drugs
OptumRx: The 3 drugs that will have the biggest impact on payers, patients in 2020
(By Maia Anderson for Becker’s Hospital Review) OptumRx, the pharmacy benefit unit of UnitedHealth Group, released a list of the three
Read MoreInsulin Costs and Coverage in Medicare Part D
(By Juliette Cubanski, Tricia Neuman, Sarah True, and Anthony Damico for Kaiser Family Foundation) In May 2020, the Trump Administration
Read MoreLancet, New England Journal retract Covid-19 studies, including one that raised safety concerns about malaria drugs
(By Andrew Joseph for STAT) The Lancet, one of the world’s top medical journals, on Thursday retracted an influential study
Read MoreOut-of-pocket insulin costs remained steady for commercial members but soared for others
According to a recent study published on JAMA Internal Medicine, its findings contradict the view that insulin cost-sharing is excessive
Read MoreTop medical journals raise concerns about data in two studies related to Covid-19
(By Matthew Herper and Andrew Joseph for STAT) Two of the world’s leading medical journals on Tuesday expressed concern about
Read MoreA repurposed cancer drug is showing encouraging results in Alzheimer’s trial
In a recent paper published in the journal Annals of Neurology, it is reporting encouraging results from a small Phase
Read MoreAre you thinking of switching from Medicare Advantage plan to a Medigap plan?
If you plan on switching to a Medigap from Medicare Advantage plan, it will require some planning. You need to
Read MoreFDA asks 5 drugmakers to recall metformin products
( By Maia Anderson for Becker’s Hospital Review) The FDA has asked five drugmakers to voluntarily recall their metformin products
Read MoreGilead’s remdesivir shows some benefit in patients with moderate Covid-19, new data show
(By Matthew Herper for STAT) Remdesivir, the drug developed as a treatment for Covid-19 by Gilead Sciences, helped patients with
Read More